The vaccine alliance GAVI announced it would invest USD 178 million to create a global stockpile of about 500,000 Ebola vaccines, a move health officials say could help prevent future outbreaks from spiralling out of control.
GAVI is a public-private partnership that includes the World Health Organisation, UNICEF, the Bill & Melinda Gates Foundation and the World Bank, among others.
The funding announcement was made Thursday after a meeting of GAVI's board in New Delhi.
Since the latest outbreak in Congo was identified last August, health officials have immunised more than 255, 000 people with a recently licensed vaccine made by Merck.
Ngozi Okonjo-Iweala, chair of Gavi's board, called the creation of the Ebola vaccine stockpile a "historic milestone in humanity's fight against this horrific disease".
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app